Weekly Report: what happened at IDNA last week (0415-0419)?

Weekly Market Pulse: Are Higher Interest Rates Good For The Economy?

Interest rates surged last week on the back of a hotter-than-expected inflation report. The rise in rates last week pushed the 10-year to its highest level since the peak at 5% in October of last year. Gold has been setting new highs, trading above $2400.

Weekly Report: what happened at IDNA last week (0408-0412)?

Weekly Report: what happened at IDNA last week (0401-0405)?

Weekly Report: what happened at IDNA last week (0325-0329)?

Weekly Report: what happened at IDNA last week (0318-0322)?

ARKG: Massive Potential, But Not Worth The Risk Yet For These 3 Reasons

ARK Genomic Revolution ETF warrants a hold rating due to underdeveloped technology, legal hurdles, and unresolved ethical dilemmas. The fund's performance has significantly underperformed the S&P 500 Index. ARKG has a relatively high expense ratio with no dividend yield and is concentrated in the healthcare sector.

GNOM: Genomics Still Waiting For Its 'ChatGPT' Moment

Global X Genomics & Biotechnology ETF invests across companies benefiting from advancements in the field of genomics within biotechnology. The fund's historical performance has been poor amid volatile stock prices for underlying holdings. Genomics may be the future, but still missing a blockbuster application to drive momentum in the segment.

Taking Stock: Q2 2024 Equity Market Outlook

Weekly Report: what happened at IDNA last week (0311-0315)?

2024 Outlook: A New 'Super Boom'? Or Chop And Churn?

Weekly Report: what happened at IDNA last week (0304-0308)?

Why Biotech Stocks May Be Ready For A Recovery

Biotech stocks have struggled in recent quarters as high interest rates take a toll on the capital-intensive sector. Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with MoneyTalk's Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a recovery.

Weekly Report: what happened at IDNA last week (0226-0301)?

Are Healthcare Stocks A Risky Prescription In A U.S. Election Year?

Weekly Report: what happened at IDNA last week (0219-0223)?

Sector Insights: What Could Go Right In 2024?

Weekly Report: what happened at IDNA last week (0212-0216)?

IDNA: Healthcare Dashboard For February

IShares Genomics Immunology and Healthcare ETF (IDNA) provides a monthly dashboard with aggregate industry metrics in the healthcare sector. We conclude with 10 healthcare stocks cheaper than their peers in February. The metrics are designed for stock-picking rather than index investing. IShares U.S. Healthcare ETF calculates the median value of five fundamental ratios for each industry.

Weekly Report: what happened at IDNA last week (0205-0209)?